Evidence map›Paper›PMID 26221370›Full record

ArticleInternational journal of clinical and experimental medicine2015

Salivary and serum biomarkers for the study of side effects of aripiprazole coprescribed with mirtazapine in rats.

Maria Bogdan, Isabela Silosi, Petra Surlin, Andrei Adrian Tica, Oana Sorina Tica, Tudor-Adrian Balseanu, Anne-Marie Rauten, Adrian Camen

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Host immune response in chronic hepatitis C infection: involvement of cytokines and inflammasomes.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria BogdanDepartment of Pharmacology, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Isabela SilosiDepartment of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Petra SurlinDepartment of Periodontology, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Andrei Adrian TicaDepartment of Pharmacology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Oana Sorina TicaDepartment of Obstetrics-Gynecology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Tudor-Adrian BalseanuDepartment of Physiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Anne-Marie RautenDepartment of Orthodontics, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova, Romania.
Adrian CamenDepartment of Dentoalveolar Surgery, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street, 200349 Craiova, Romania.
University of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate whether the co-administration of aripiprazole and mirtazapine could determine weight gain and lipid metabolism disorders in Wistar rats, compared to the same side effects produced by mirtazapine alone, and the risk of hepatotoxicity due to the combination of the two substances. Tumor necrosis factor alpha (TNF-α), liver fatty acid binding protein (L-FABP/FABP1) and repulsive guidance molecule C/hemojuvelin (RGM-C/HJV) levels were determined in serum and in saliva. Also, serum levels for total cholesterol (TC), low and high-density lipoprotein (LDL, HDL), triglycerides (TG), aspartate aminotransferase (ASAT) and alanine amino transferase (ALAT) were assessed. We found positive and statistically significant correlations between serum and salivary levels of TNF-α, L-FABP/FABP1 and RGM-C/HJV. Mirtazapine determined significantly differences of TNF-α and L-FABP serum levels; final body weight; TC and LDL levels, leading to higher concentrations than its association with aripiprazole. Although not statistically significant, mirtazapine group experienced higher values for salivary levels of TNF-α, TG and ASAT, and lower values for HDL, compared to aripiprazole + mirtazapine group. The results suggest that aripiprazole might improve some of the disturbances caused by mirtazapine, and that the two drugs combination cause no additional alterations in liver function. Also, the findings indicate that TNF-α, L-FABP/FABP1 and RGM-C/HJV levels can be helpful as biomarkers for metabolic disturbances and impaired function of hepatocytes, and that their salivary determination can replace serum determination.

Indexed as

AripiprazolehepatotoxicityL-FABP/FABP1lipid metabolism disordersmirtazapineRGM-C/HJVTNF-αweight gain

Identifiers

PMID26221370
PMCPMC4509315
OpenAlexW2397981846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.